Spyre Therapeutics prices $350M public offering at $85 per share
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
Solana Foundation launched an open-source program that lets institutions settle trades in seconds, not days. JPMorgan provided key inputs.
Spot gold slipped 0.3% to $4,128.83 per ounce by 0400 GMT
Eqyizen will use the proceeds to meet an obligation of Porteast Investment, another group subsidiary, which is due to pay around ₹3,500 crore for debt raised in May 2025